Form 4: Cue Biopharma's Chief Medical Officer, Matteo Levisetti, Granted Stock Options

Matteo Levisetti, Chief Medical Officer of Cue Biopharma, Inc., was granted stock options to purchase 125,000 shares of common stock on June 5, 2024.

Summary

• On June 5, 2024, Matteo Levisetti, the Chief Medical Officer of Cue Biopharma, Inc., was granted stock options.
• These options allow him to purchase 125,000 shares of Cue Biopharma's common stock at an exercise price of $1.65 per share.
• The stock options vest in eight equal semi-annual installments, starting on December 5, 2024.
• The options expire on June 4, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management interests with shareholders.

Positives

• The granting of stock options to the Chief Medical Officer aligns his interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

Stock options are a common form of executive compensation in the biotechnology industry, used to attract and retain talent and align their interests with those of shareholders. This grant is typical for a Chief Medical Officer in a company like Cue Biopharma.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotech industry.
• Companies like Amgen, Gilead, and Biogen routinely use stock options to incentivize their executives.
• The vesting schedule of semi-annual installments over four years is also a common practice.
• The number of shares granted and the exercise price would be benchmarked against similar companies based on market capitalization and stage of development.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive incentive for the Chief Medical Officer.
• Employees may see this as a sign of the company's commitment to its leadership team.

Key Dates